 |
|
Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
Jin-Woo Kim, Mi Kyung Kwak, Jeong Joon Han, Sung-Tak Lee, Ha Young Kim, Se Hwa Kim, Junho Jung, Jeong Keun Lee, Young-Kyun Lee, Yong-Dae Kwon, Deog-Yoon Kim
J Bone Metab. 2021;28(4):279-296. Published online 2021 Nov 30 DOI: https://doi.org/10.11005/jbm.2021.28.4.279
|
|
Citations to this article as recorded by
 Zoledronate/Anti-VEGF Neutralizing Antibody Combination Administration Increases Osteal Macrophages in a Murine Model of MRONJ Stage 0-like Lesions
Haruka Kaneko, Shinichiro Kuroshima, Ryohei Kozutsumi, Farah A. Al-Omari, Hiroki Hayano, Kazunori Nakajima, Takashi Sawase
Journal of Clinical Medicine.2023; 12(5): 1914. CrossRef Oral Health-Related Quality of Life and Mental Health Impairment in Patients Affected by Medication-Related Osteonecrosis of the Jaws: A Case–Control Pilot Study
Elena Calabria, Alessandro Antonelli, Selene Barone, Daniela Adamo, Marianna Salviati, Maria Giulia Cerra, Francesco Bennardo, Amerigo Giudice
Dentistry Journal.2023; 11(6): 147. CrossRef Medication-related Osteonecrosis of the Jaw Induced by Regenerative Therapy in Implant Dentistry: A Scoping Review
Farah A. Al-Omari, Shinichiro Kuroshima, Takashi Sawase
Journal of Dentistry.2023; 138: 104682. CrossRef Risk factors for the development of medication-related osteonecrosis of the jaw and effects of tooth extraction with local infection
Norio Nakamura, Mitsunobu Otsuru, Taro Miyoshi, Koki Suyama, Keisuke Omori, Kota Morishita, Sakiko Soutome, Satoshi Rokutanda, Kei-ichiro Miura, Masahiro Umeda
Journal of Dental Sciences.2023;[Epub] CrossRef Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review
Jinyoung Kim, Chaiho Jeong, Jeongmin Lee, Jeonghoon Ha, Ki-Hyun Baek, Seohyun Kim, Tai Joon An, Chan Kwon Park, Hyoung Kyu Yoon, Jeong Uk Lim
Seminars in Oncology.2023; 50(3-5): 105. CrossRef Bone resection methods in medication-related osteonecrosis of the jaw in the mandible: An investigation of 206 patients undergoing surgical treatment
Koki Suyama, Mitsunobu Otsuru, Norio Nakamura, Kota Morishita, Taro Miyoshi, Keisuke Omori, Kei-ichiro Miura, Sakiko Soutome, Saki Hayashida, Satoshi Rokutanda, Masahiro Umeda
Journal of Dental Sciences.2023;[Epub] CrossRef Effects of daily versus weekly teriparatide for medication‐related osteonecrosis of the jaw: A case–control study
Kang‐Min Kim, Sehyang Kim, Hyun Hwang, Hey‐Yun Kim, Dohyun Kim, Jung‐Hyun Park, HyeRan Choo, Jin‐Woo Kim
Oral Diseases.2023;[Epub] CrossRef Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw
Sebastian Blatt, Maximilian Krüger, Peer W. Kämmerer, Daniel G. E. Thiem, Philipp Matheis, Anne-Katrin Eisenbeiß, Jörg Wiltfang, Bilal Al-Nawas, Hendrik Naujokat
Journal of Clinical Medicine.2022; 11(3): 682. CrossRef Medication-Related Osteonecrosis of the Jaws: A Literature Review
Gyeong-Mi Kim, Seong-Yong Moon, Jae-Seek You, Gyeong-Yun Kim, Ji-Su Oh
Journal of Oral Medicine and Pain.2022; 47(1): 1. CrossRef Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw
Mitsunobu Otsuru, Sakiko Soutome, Keisuke Omori, Koki Suyama, Kota Morishita, Saki Hayashida, Maho Murata, Yukinori Takagi, Miho Sasaki, Misa Sumi, Yuka Kojima, Shunsuke Sawada, Yuki Sakamoto, Masahiro Umeda
International Journal of Environmental Research and Public Health.2022; 19(8): 4624. CrossRef The Role of Geranylgeraniol in Managing Bisphosphonate-Related Osteonecrosis of the Jaw
Kok-Yong Chin, Sophia Ogechi Ekeuku, Anne Trias
Frontiers in Pharmacology.2022;[Epub] CrossRef Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study
Sakiko Soutome, Mitsunobu Otsuru, Maho Murata, Kota Morishita, Keisuke Omori, Koki Suyama, Saki Hayashida, Masahiro Umeda, Toshiyuki Saito
Supportive Care in Cancer.2022; 30(9): 7241. CrossRef Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
E. M. Spevak, D. Yu. Christophorando, V. A. Shutov, A. V. Ermakova
Creative surgery and oncology.2022; 12(2): 151. CrossRef Ineffectiveness of Antiresorptive Agent Drug Holidays in Osteoporosis Patients for Treatment of Medication-Related Osteonecrosis of the Jaw: Consideration from Immunohistological Observation of Osteoclast Suppression and Treatment Outcomes
Keisuke Omori, Mitsunobu Otsuru, Kota Morishita, Saki Hayashida, Koki Suyama, Tomofumi Naruse, Sakiko Soutome, Masahiro Umeda
International Journal of Environmental Research and Public Health.2022; 19(17): 10898. CrossRef
|